Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients
Claudio Napoli, Giuditta Benincasa, Concetta Schiano, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2019) Vol. 6, Iss. 4, pp. 239-247
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases
Concetta Schiano, Giuditta Benincasa, Monica Franzese, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107514-107514
Closed Access | Times Cited: 116
Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics
Claudio Napoli, Giuditta Benincasa, Francesco Donatelli, et al.
American Heart Journal (2020) Vol. 224, pp. 113-128
Open Access | Times Cited: 80
Deacetylation of Caveolin-1 by Sirt6 induces autophagy and retards high glucose-stimulated LDL transcytosis and atherosclerosis formation
Ying Zhao, Xiong Jia, Xiaoyan Yang, et al.
Metabolism (2022) Vol. 131, pp. 155162-155162
Open Access | Times Cited: 55
Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: Novel opportunities for primary prevention
Giuditta Benincasa, Enrico Coscioni, Claudio Napoli
Biochemical Pharmacology (2022) Vol. 202, pp. 115108-115108
Closed Access | Times Cited: 55
Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases
Zujie Xu, Binbin Lv, Ying Qin, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1101-1101
Open Access | Times Cited: 43
Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications
Albert Sufianov, А. А. Костин, Sema Begliarzade, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 2, pp. 192-204
Open Access | Times Cited: 23
Epigenetics and pulmonary diseases in the horizon of precision medicine: a review
Giuditta Benincasa, Dawn L. DeMeo, Kimberly Glass, et al.
European Respiratory Journal (2020) Vol. 57, Iss. 6, pp. 2003406-2003406
Open Access | Times Cited: 67
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside
Federica Sarno, Giuditta Benincasa, Markus List, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 53
Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
Ettore Crimi, Giuditta Benincasa, Neisaliz Figueroa-Marrero, et al.
British Journal of Anaesthesia (2020) Vol. 125, Iss. 6, pp. 1002-1017
Open Access | Times Cited: 52
Clinical epigenetics and acute/chronic rejection in solid organ transplantation: An update
Maria Vasco, Giuditta Benincasa, Carmela Fiorito, et al.
Transplantation Reviews (2021) Vol. 35, Iss. 2, pp. 100609-100609
Closed Access | Times Cited: 50
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients: a meta-analysis of randomized clinical trials
Rosaria Benedetti, Giuditta Benincasa, Kimberly Glass, et al.
Pharmacological Research (2021) Vol. 175, pp. 106039-106039
Closed Access | Times Cited: 48
Diabetes and Its Cardiovascular Complications: Potential Role of the Acetyltransferase p300
Nadia Di Pietrantonio, Pamela Di Tomo, Domitilla Mandatori, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 431-431
Open Access | Times Cited: 18
Strengths and Opportunities of Network Medicine in Cardiovascular Diseases
Giuditta Benincasa, Raffaele Marfella, Nunzia Della Mura, et al.
Circulation Journal (2019) Vol. 84, Iss. 2, pp. 144-152
Open Access | Times Cited: 53
Soft drinks and sweeteners intake: Possible contribution to the development of metabolic syndrome and cardiovascular diseases. Beneficial or detrimental action of alternative sweeteners?
Concetta Schiano, Vincenzo Grimaldi, Michele Scognamiglio, et al.
Food Research International (2021) Vol. 142, pp. 110220-110220
Open Access | Times Cited: 38
Epigenetic Therapies for Heart Failure: Current Insights and Future Potential
Claudio Napoli, Paola Bontempo, Vittorio Palmieri, et al.
Vascular Health and Risk Management (2021) Vol. Volume 17, pp. 247-254
Open Access | Times Cited: 37
The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia
Mark E. Pepin, Concetta Schiano, Marco Miceli, et al.
Experimental Cell Research (2021) Vol. 400, Iss. 2, pp. 112485-112485
Open Access | Times Cited: 33
Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases
Giuditta Benincasa, Rosa Suades, Teresa Padró, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 8, pp. 758-769
Closed Access | Times Cited: 11
The Role of Epigenetics in Cardiovascular Disease: Providing Insights into Disease Mechanisms and Evaluating Therapeutic Potential for Future Treatment Strategies
Omar Elsaka
APIK Journal of Internal Medicine (2025)
Open Access
Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections
Ankita Saha, Anirban Ganguly, Anoop Kumar, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 129-129
Open Access
Clonal hematopoiesis of indeterminate potential, health indicators, and risk of cardiovascular diseases among patients with diabetes: a prospective cohort study
Ying Sun, Yuefeng Yu, Lingli Cai, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
MicroRNA-126: From biology to therapeutics
Bei Guo, Jia Gu, Tongtian Zhuang, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117953-117953
Closed Access
Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study
Paolo Sorino, Maria Gabriella Caruso, Giovanni Misciagna, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240867-e0240867
Open Access | Times Cited: 32
Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness
Ettore Crimi, Giuditta Benincasa, Silvia Cirri, et al.
Epigenetics (2020) Vol. 15, Iss. 10, pp. 1021-1034
Open Access | Times Cited: 30
Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs
Gelsomina Mansueto, Giuditta Benincasa, Nunzia Della Mura, et al.
Journal of Clinical Pathology (2020) Vol. 73, Iss. 9, pp. 535-543
Open Access | Times Cited: 29
Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus
Raushan Zh Karabaeva, Tamara Vochshenkova, Nadiar M. Mussin, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top